Molina Healthcare, Inc. (NYSE:MOH) Director Dale B. Wolf sold 4,000 shares of the business’s stock in a transaction on Friday, November 9th. The stock was sold at an average price of $135.57, for a total value of $542,280.00. Following the transaction, the director now directly owns 10,214 shares of the company’s stock, valued at $1,384,711.98. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

NYSE:MOH opened at $134.16 on Friday. The stock has a market cap of $8.49 billion, a PE ratio of 19.38, a price-to-earnings-growth ratio of 1.32 and a beta of 1.52. Molina Healthcare, Inc. has a 1 year low of $71.07 and a 1 year high of $154.06. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 0.78.

Molina Healthcare (NYSE:MOH) last released its quarterly earnings data on Wednesday, October 31st. The company reported $2.55 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.65 by $0.90. The business had revenue of $4.70 billion during the quarter, compared to analysts’ expectations of $4.72 billion. Molina Healthcare had a return on equity of 30.50% and a net margin of 1.27%. The business’s quarterly revenue was down 6.6% compared to the same quarter last year. During the same period in the prior year, the firm posted ($1.62) EPS. As a group, research analysts forecast that Molina Healthcare, Inc. will post 7.91 earnings per share for the current year.

Several research firms recently commented on MOH. Bank of America boosted their target price on Molina Healthcare from $94.00 to $110.00 and gave the stock an “underperform” rating in a research note on Wednesday, August 1st. Jefferies Financial Group cut Molina Healthcare from a “buy” rating to a “hold” rating and set a $152.00 price objective for the company. in a research report on Friday, October 12th. They noted that the move was a valuation call. ValuEngine cut Molina Healthcare from a “buy” rating to a “hold” rating in a research report on Thursday, November 1st. Wells Fargo & Co upped their price objective on Molina Healthcare from $92.00 to $120.00 and gave the stock a “market perform” rating in a research report on Thursday, August 2nd. Finally, Morgan Stanley upped their price objective on Molina Healthcare from $108.00 to $132.00 and gave the stock an “overweight” rating in a research report on Thursday, August 2nd. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus price target of $130.62.

Several hedge funds and other institutional investors have recently made changes to their positions in MOH. Advisors Asset Management Inc. boosted its position in shares of Molina Healthcare by 2,264.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 93,813 shares of the company’s stock valued at $118,000 after purchasing an additional 89,845 shares during the period. Integrated Investment Consultants LLC acquired a new stake in shares of Molina Healthcare in the 2nd quarter valued at about $165,000. Contravisory Investment Management Inc. acquired a new stake in shares of Molina Healthcare in the 2nd quarter valued at about $166,000. DekaBank Deutsche Girozentrale boosted its position in shares of Molina Healthcare by 185.1% in the 3rd quarter. DekaBank Deutsche Girozentrale now owns 1,226 shares of the company’s stock valued at $170,000 after purchasing an additional 796 shares during the period. Finally, Alpha Cubed Investments LLC acquired a new stake in shares of Molina Healthcare in the 3rd quarter valued at about $200,000.

COPYRIGHT VIOLATION WARNING: This news story was first posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this news story on another publication, it was illegally copied and republished in violation of United States & international copyright & trademark legislation. The legal version of this news story can be viewed at https://theolympiareport.com/2018/11/11/molina-healthcare-inc-moh-director-sells-542280-00-in-stock.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Further Reading: What is a Call Option?

Insider Buying and Selling by Quarter for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.